SCHEMBL19735040

SCHEMBL19735040

Cc1cc(C(OS(C)(=O)=O)C(N)=O)c(F)cn1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29658743 0.87
SCHEMBL19717478 0.87
SCHEMBL19734432 0.76 APP (0.38) PTGS2
SCHEMBL19734434 0.76 NPC1 (0.33) PTGS2
SCHEMBL29658493 0.76 TDP1 (0.34) PTGS2
SCHEMBL19716964 0.76 TDP1 (0.34) PTGS2
SCHEMBL29658697 0.72 CES2 (0.42) PTGS2
SCHEMBL19717706 0.72 CES2 (0.42) PTGS2
SCHEMBL19717609 0.71 CCNC (0.38)
SCHEMBL29658527 0.71 CCNC (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017216726-A1 SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-12-21 WO disclosed
WO-2017216727-A1 SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-12-21 WO disclosed